Soligenix stock rallies 400% on positive HyBryte trial results - Invezz
Soligenix, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $0.83
+142% in 7d after detection
Post-detection moves
1h
—
1d
+3.2%
3d
+3.9%
7d
+142%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS